Fisher Patrick sold $1K of OFIX
Fisher Patrick (President, Global Limb Recon) sold 150 shares of Orthofix Medical Inc. (OFIX) at $9.39 on 2026-09-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is routine and unlikely to move the stock, but it provides transparency for investors.
Market read
Minor insider sale with negligible market impact; primarily of interest to compliance‑focused investors.
What to watch
Potential upcoming corporate actions or financing needs not disclosed.
Background
Form 4 filings disclose insider transactions; a 10b5-1 plan indicates pre‑arranged sales.
Ticker impact
President Fisher Patrick sold 150 shares for $1,408.50 via a 10b5-1 plan, filing a Form 4 on Sep 3, 2026.
Likely negligible effect on OFIX price.
The transaction represents less than 0.01% of total shares outstanding and is disclosed as a routine 10b5-1 sale.
Market effects
No broader sector impact; Orthofix operates in medical devices niche.
Limited to US small‑cap investors.
Minimal global relevance.
Counterpoint
Even small insider sales can signal confidence concerns; monitor for further disposals.
Key entities
- OfficerFisher Patrick
President, Global Limb Recon at Orthofix Medical.
